Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Backman, Ludvig J ^a,b   Fong, Gloria ^a,b,c   Andersson, Gustav ^a   Scott, Alexander ^b,c   Danielson, Patrik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROKININ 1 RECEPTOR; SUBSTANCE P; TENOMODULIN; UNCLASSIFIED DRUG; VIMENTIN;

ACHILLES TENDON; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; MUSCLE CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TENOCYTE; WESTERN BLOTTING;

ACHILLES TENDON; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; IMMUNOENZYME TECHNIQUES; MECHANOTRANSDUCTION, CELLULAR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBSTANCE P;

EID: 80055121883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027209     Document Type: Article

References (49)

1. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M, (1999) Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 27: 393-408.
2. Danielson P, (2009) Reviving the "biochemical" hypothesis for tendinopathy: new findings suggest the involvement of locally produced signal substances. Br J Sports Med 43: 265-268.
3. Khan KM, Cook JL, Maffulli N, Kannus P, (2000) Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med 34: 81-83.
4. Bjur D, Danielson P, Alfredson H, Forsgren S, (2008) Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res 331: 385-400.
5. Danielson P, Alfredson H, Forsgren S, (2006) Immunohistochemical and histochemical findings favoring the occurrence of autocrine/paracrine as well as nerve-related cholinergic effects in chronic painful patellar tendon tendinosis. Microsc Res Tech 69: 808-819.
6. Danielson P, Andersson G, Alfredson H, Forsgren S, (2007) Extensive expression of markers for acetylcholine synthesis and of M2 receptors in tenocytes in therapy-resistant chronic painful patellar tendon tendinosis-a pilot study. Life Sci 80: 2235-2238.
7. Bjur D, Danielson P, Alfredson H, Forsgren S, (2008) Immunohistochemical and in situ hybridization observations favor a local catecholamine production in the human Achilles tendon. Histol Histopathol 23: 197-208.
8. Danielson P, Alfredson H, Forsgren S, (2007) Studies on the importance of sympathetic innervation, adrenergic receptors, and a possible local catecholamine production in the development of patellar tendinopathy (tendinosis) in man. Microsc Res Tech 70: 310-324.
9. Danielson P, Alfredson H, Forsgren S, (2007) In situ hybridization studies confirming recent findings of the existence of a local nonneuronal catecholamine production in human patellar tendinosis. Microsc Res Tech 70: 908-911.
10. Scott A, Alfredson H, Forsgren S, (2008) VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes. J Orthop Res 26: 685-692.
11. Andersson G, Danielson P, Alfredson H, Forsgren S, (2008) Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept 150: 81-87.
12. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ, (1993) Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 110: 43-49.
13. Burssens P, Steyaert A, Forsyth R, van Ovost EJ, Depaepe Y, et al. (2005) Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot Ankle Int 26: 832-839.
14. Carlsson O, Schizas N, Li J, Ackermann PW, (2011) Substance P injections enhance tissue proliferation and regulate sensory nerve ingrowth in rat tendon repair. Scand J Med Sci Sports 21: 562-569.
15. Messner K, Wei Y, Andersson B, Gillquist J, Rasanen T, (1999) Rat model of Achilles tendon disorder. A pilot study. Cells Tissues Organs 165: 30-39.
16. Schubert TE, Weidler C, Lerch K, Hofstadter F, Straub RH, (2005) Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann Rheum Dis 64: 1083-1086.
17. Forsgren S, Danielson P, Alfredson H, (2005) Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: studies on chemically unfixed as well as fixed specimens. Regul Pept 126: 173-181.
18. Maggi CA, (1995) The mammalian tachykinin receptors. General pharmacology 26: 911-944.
19. New DC, Wong YH, (2007) Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal 2: 2.
20. Koon HW, Zhao D, Na X, Moyer MP, Pothoulakis C, (2004) Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J Biol Chem 279: 45519-45527.
21. Yamaguchi K, Richardson MD, Bigner DD, Kwatra MM, (2005) Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCdelta. Cancer Chemother Pharmacol 56: 585-593.
22. Goodman SA, May SA, Heinegard D, Smith RK, (2004) Tenocyte response to cyclical strain and transforming growth factor beta is dependent upon age and site of origin. Biorheology 41: 613-628.
23. Millward-Sadler SJ, Salter DM, (2004) Integrin-dependent signal cascades in chondrocyte mechanotransduction. Ann Biomed Eng 32: 435-446.
24. Andersson G, Forsgren S, Scott A, Gaida JE, Stjernfeldt JE, et al. (2011) Tenocyte hypercellularity and vascular proliferation in a rabbit model of tendinopathy: contralateral effects suggest the involvement of central neuronal mechanisms. Br J Sports Med 45: 399-406.
25. Backman C, Boquist L, Friden J, Lorentzon R, Toolanen G, (1990) Chronic achilles paratenonitis with tendinosis: an experimental model in the rabbit. J Orthop Res 8: 541-547.
26. Backman LJ, Andersson G, Wennstig G, Forsgren S, Danielson P, (2011) Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathy-peptidergic elevation preceding tendinosis-like tissue changes. J Musculoskelet Neuronal Interact 11: 133-140.
27. Andersson G, Backman LJ, Scott A, Lorentzon R, Forsgren S, et al. (2011) Substance P accelerates hypercellularity and angiogenesis in tendon tissue and enhances paratendinitis in response to Achilles tendon overuse in a tendinopathy model. Br J Sports Med 45: 1017-1022.
28. Scott A, Danielson P, Abraham T, Fong G, Sampaio AV, et al. (2011) Mechanical force modulates scleraxis expression in bioartificial tendons. J Musculoskelet Neuronal Interact 11: 124-132.
29. Koon HW, Zhao D, Zhan Y, Moyer MP, Pothoulakis C, (2007) Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc Natl Acad Sci U S A 104: 2013-2018.
30. Corps AN, Jones GC, Harrall RL, Curry VA, Hazleman BL, et al. (2008) The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 27: 393-401.
31. Courneya JP, Luzina IG, Zeller CB, Rasmussen JF, Bocharov A, et al. (2010) Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes. Fibrogenesis Tissue Repair 3: 9.
32. de Mos M, Koevoet W, van Schie HT, Kops N, Jahr H, et al. (2009) In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med 37: 1214-1222.
33. Józsa L, Kannus P, (1997) Human tendons: Anatomy, physiology, and pathology. Champaign, IL, USA Human Kinetics.
34. Kvist M, Jozsa L, Jarvinen MJ, Kvist H, (1987) Chronic Achilles paratenonitis in athletes: a histological and histochemical study. Pathology 19: 1-11.
35. Zhang J, Wang JH, (2010) Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 11: 10.
36. Rufai A, Benjamin M, Ralphs JR, (1992) Development and ageing of phenotypically distinct fibrocartilages associated with the rat Achilles tendon. Anat Embryol (Berl) 186: 611-618.
37. Docheva D, Hunziker EB, Fassler R, Brandau O, (2005) Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25: 699-705.
38. Jelinsky SA, Archambault J, Li L, Seeherman H, (2010) Tendon-selective genes identified from rat and human musculoskeletal tissues. J Orthop Res 28: 289-297.
39. Shukunami C, Takimoto A, Oro M, Hiraki Y, (2006) Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 298: 234-247.
40. Santoni G, Amantini C, Lucciarini R, Pompei P, Perfumi M, et al. (2002) Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Neuroimmunomodulation 10: 232-246.
41. Fedorczyk JM, Barr AE, Rani S, Gao HG, Amin M, et al. (2010) Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthop Res 28: 298-307.
42. Lai JP, Lai S, Tuluc F, Tansky MF, Kilpatrick LE, et al. (2008) Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor. Proc Natl Acad Sci U S A 105: 12605-12610.
43. Tansky MF, Pothoulakis C, Leeman SE, (2007) Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor. Proc Natl Acad Sci U S A 104: 10691-10696.
44. Lind H, Brudin L, Lindholm L, Edvinsson L, (1996) Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man. Clin Physiol 16: 73-82.
45. Cottrell GS, Padilla B, Pikios S, Roosterman D, Steinhoff M, et al. (2006) Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J Biol Chem 281: 27773-27783.
46. Bennett VJ, Perrine SA, Simmons MA, (2002) A novel mechanism of neurokinin-1 receptor resensitization. J Pharmacol Exp Ther 303: 1155-1162.
47. Kahler CM, Herold M, Reinisch N, Wiedermann CJ, (1996) Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol 166: 601-608.
48. Kahler CM, Herold M, Wiedermann CJ, (1993) Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol 156: 579-587.
49. Steyaert A, Burssens P, Forsyth R, Vanderstraeten G, (2010) Qualitative analysis of substance P, NK1-receptor and nerve ingrowth in substance P-treated ruptured rat Achilles tendon. Acta Orthop Belg 76: 387-395.